by Bruce Brown | June 30, 2022 | Medical
Following FDA clearance for its long-lasting Eversense E3 CGM System (continuous glucose monitoring) earlier this year, Senseonics’ Ascensia Diabetes Care division announced CE Mark approval for the platform. Alfred Poor first wrote about FDA approval for the...
by Bruce Brown | March 11, 2022 | Medical
The FDA recently granted Breakthrough Device Designation for the use of Dexcom’s continuous glucose monitoring (CGM) with diabetic patients in hospitals. Chalk up yet another potential digital health tech win with direct ties to the COVID-19 pandemic. The FDA...
by Bruce Brown | August 9, 2021 | Medical
We have followed the development and maturation of wearable continuous glucose monitors (CGM) solutions since 2014. In 2015, we wrote about the Animas Vibe insulin pump that connected wirelessly to a Dexcom G4 CGM. This past March we covered a new partnership between...
by Bruce Brown | June 17, 2020 | Medical
Continuous glucose monitoring (CGM) devices improve the lives of people with diabetes by minimizing or eliminating the need for painful and inconvenient finger stick blood glucose tests. We’ve written about CGMs from several companies and research organizations,...
by Alfred Poor | February 21, 2020 | Medical
Diabetes is a chronic condition in which the body fails to properly regulate blood sugar levels. Treatment often involves finger pricks to measure glucose levels, followed by insulin injections to maintain the desired range. This approach has many inconvenient,...